Scarica l'app Stockscreener
107.03
0.43%
-0.5081
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$107.54
Aprire:
$107.17
Volume 24 ore:
89,972
Relative Volume:
0.05
Capitalizzazione di mercato:
$21.20B
Reddito:
$7.68B
Utile/perdita netta:
$903.80M
Rapporto P/E:
24.05
EPS:
4.45
Flusso di cassa netto:
$1.14B
1 W Prestazione:
+1.30%
1M Prestazione:
+9.77%
6M Prestazione:
+2.91%
1 anno Prestazione:
-6.62%
Intervallo 1D:
$106.84
$107.85
Intervallo di 1 settimana:
$104.13
$108.29
Portata 52W:
$89.24
$116.71
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Confronta ZBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
107.02 | 21.26B | 7.68B | 903.80M | 1.14B | 4.45 |
|
ABT
Abbott Laboratories
|
130.99 | 229.51B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.24 | 155.75B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
393.89 | 149.44B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
91.54 | 117.93B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.46 | 47.47B | 5.69B | 1.41B | 577.90M | 6.95 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-15 | Aggiornamento | Roth Capital | Neutral → Buy |
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Zimmer Biomet's Dividend Resilience: A Cornerstone of Shareholder Value in a Post-Pandemic Medical Device Sector - AInvest
Zimmer Biomet Holdings, Inc. Announces Quarterly Cash Dividend forThird Quarter of 2025, Payable on or About October 31, 2025 - MarketScreener
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025 - PR Newswire
Real time pattern detection on Zimmer Biomet Holdings Inc. stockTrend Reversal & Stepwise Swing Trade Plans - Newser
Will Zimmer Biomet Holdings Inc. benefit from macro trendsPortfolio Profit Report & AI Enhanced Trading Alerts - Newser
Is Zimmer Biomet Holdings Inc. meeting your algorithmic filter criteriaJuly 2025 Weekly Recap & Safe Swing Trade Setups - Newser
What MACD signals say about Zimmer Biomet Holdings Inc.2025 Growth vs Value & Weekly Watchlist for Hot Stocks - Newser
Is Zimmer Biomet Holdings Inc. reversing from oversold territoryJuly 2025 Price Swings & Verified Momentum Stock Watchlist - Newser
How moving averages guide Zimmer Biomet Holdings Inc. tradingWeekly Volume Report & Real-Time Volume Analysis Alerts - Newser
Analyzing net buyer seller activity in Zimmer Biomet Holdings Inc.2025 EndofYear Setup & Safe Capital Investment Plans - Newser
What to do if you’re stuck in Zimmer Biomet Holdings Inc.July 2025 Catalysts & Smart Allocation Stock Reports - Newser
Tools to assess Zimmer Biomet Holdings Inc.’s risk profileTrade Analysis Report & Daily Risk Controlled Trade Plans - Newser
Zimmer Biomet Holdings Inc. stock outlook for YEAR2025 Fundamental Recap & Capital Protection Trading Alerts - Newser
Risk adjusted return profile for Zimmer Biomet Holdings Inc. analyzedQuarterly Growth Report & Verified Swing Trading Watchlist - Newser
Zimmer Biomet Holdings Inc. stock trend outlook and recovery path2025 Risk Factors & Growth-Oriented Investment Plans - Newser
Published on: 2025-08-26 11:39:11 - Newser
Is Zimmer Biomet Holdings Inc. a candidate for recovery playSell Signal & High Return Stock Watch Alerts - Newser
Visual trend scoring systems applied to Zimmer Biomet Holdings Inc.July 2025 Closing Moves & Free Community Supported Trade Ideas - Newser
Zimmer Biomet Presents at Morgan Stanley Healthcare Conference on Sept. 8. - AInvest
Zimmer Biomet to Present at the Annual Morgan Stanley Healthcare Conference - Morningstar
How to escape a deep drawdown in Zimmer Biomet Holdings Inc.July 2025 Closing Moves & Technical Analysis for Trade Confirmation - Newser
Using data filters to optimize entry into Zimmer Biomet Holdings Inc.July 2025 Sector Moves & Stepwise Trade Execution Plans - Newser
Why Zimmer Biomet Holdings Inc. stock attracts strong analyst attentionMarket Growth Summary & Verified Stock Trade Ideas - beatles.ru
Using Bollinger Bands to evaluate Zimmer Biomet Holdings Inc.2025 Valuation Update & Community Supported Trade Ideas - Newser
Tick level data insight on Zimmer Biomet Holdings Inc. volatility2025 Stock Rankings & Technical Pattern Based Signals - Newser
Ranking Zimmer Biomet Holdings Inc. among high performing stocks via tools2025 Historical Comparison & Stock Market Timing Techniques - Newser
Published on: 2025-08-23 03:09:38 - Newser
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Zimmer Biomet Delivers Solid Q2 – All Eyes on Robotics and Monogram - Orthopedics This Week
Heatmap Data Shows High Activity in Zimmer Biomet Holdings Inc. Sector2025 Big Picture & Short-Term Trading Alerts - beatles.ru
What moving averages say about Zimmer Biomet Holdings Inc.Portfolio Gains Report & Long Hold Capital Preservation Plans - Newser
Zimmer Biomet Holdings Inc. Inches Above Key Support — Safe to HoldJuly 2025 Action & AI Driven Price Forecasts - beatles.ru
Do Wall Street Analysts Like Zimmer Biomet Stock? - Barchart.com
Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock - Yahoo Finance
North America Pectus Bar Market Forecast Report to 2031, - GlobeNewswire
North America Pectus Bar Market Forecast Report to 2031, with Leading Player Profiles for KLS Martin Group, Biotech, Zimmer Biomet Holdings, Ventura Medical Technologies, and MedXpert - Yahoo Finance
Should I hold or sell Zimmer Biomet Holdings Inc. nowJuly 2025 Selloffs & Accurate Entry and Exit Point Alerts - newsyoung.net
Monogram Technologies Announces Merger with Zimmer Biomet - MSN
Stock Analysis | Zimmer Biomet OutlookA Divergent Picture Between Strong Fundamentals and Weak Technicals - AInvest
Monogram Technologies Inc. SEC 10-Q Report - TradingView
Is Zimmer Biomet Holdings Inc. still a buy after recent gainsPortfolio Profit Report & Daily Technical Stock Forecast Reports - thegnnews.com
Zimmer Biomet Holdings: Unusual Items Mask Strong Profit Growth - AInvest
Published on: 2025-08-14 17:26:03 - beatles.ru
Zimmer Biomet’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Zimmer Biomet’s Strong Q2 Performance and Optimistic Outlook - The Globe and Mail
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term - Yahoo Finance
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q2 2025 Earnings Call Transcript - MSN
Zimmer Biomet Expects Strong Q2 Earnings, Raises Guidance on Robust Performance and Strategic Acquisitions - AInvest
Orthopedic Devices Company Evaluation Report 2024-2025 | Stryker, Zimmer Biomet, and Johnson & Johnson MedTech Lead Across Joint Replacement, Trauma, and Surgical Solutions - Yahoo Finance
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.16%
0.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):